Barclays’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
66,199
+19,586
|
|
||||
|
2025
Q1 | $122K | Sell |
46,613
-18,748
|
|
||||
|
2024
Q4 | $232K | Buy |
65,361
+24,717
|
|
||||
|
2024
Q3 | $186K | Buy |
40,644
+30,902
|
|
||||
|
2024
Q2 | $43K | Sell |
9,742
-10,562
|
|
||||
|
2024
Q1 | $102K | Sell |
20,304
-19,381
|
|
||||
|
2023
Q4 | $249K | Buy |
39,685
+34,563
|
|
||||
|
2023
Q3 | $37K | Sell |
5,122
-634
|
|
||||
|
2023
Q2 | $58K | Sell |
5,756
-67,692
|
|
||||
|
2023
Q1 | $666K | Buy |
+73,448
|
|
||||
|
2021
Q4 | – | Sell |
-814
|
|
||||
|
2021
Q3 | $5K | Buy |
814
+44
|
|
||||
|
2021
Q2 | $5K | Sell |
770
-5,079
|
|
||||
|
2021
Q1 | $39K | Buy |
5,849
+3,591
|
|
||||
|
2020
Q4 | $12K | Sell |
2,258
-865
|
|
||||
|
2020
Q3 | $24K | Buy |
3,123
+138
|
|
||||
|
2020
Q2 | $22K | Buy |
+2,985
|
|
||||
|
2019
Q4 | – | Sell |
-142
|
|
||||
|
2019
Q3 | $1K | Buy |
142
+141
|
|
||||
|
2019
Q2 | $0 | Sell |
1
-2,086
|
|
||||
|
2019
Q1 | $6K | Buy |
2,087
+1,890
|
|
||||
|
2018
Q4 | $1K | Sell |
197
-2,521
|
|
||||
|
2018
Q3 | $16K | Buy |
2,718
+2,000
|
|
||||
|
2018
Q2 | $3K | Sell |
718
-807
|
|
||||
|
2018
Q1 | $19K | Buy |
+1,525
|
|